119 HR 4396 IH: Uterine Cancer Study Act of 2025 U.S. House of Representatives 2025-07-15 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

I119th CONGRESS1st SessionH. R. 4396IN THE HOUSE OF REPRESENTATIVESJuly 15, 2025Ms. Clarke of New York (for herself, Ms. Brown, Mrs. Watson Coleman, Ms. Kelly of Illinois, Mr. David Scott of Georgia, Ms. Norton, Ms. Sewell, Mrs. Foushee, Ms. McClellan, Ms. Velázquez, Mr. Fields, Mrs. Dingell, Ms. Tlaib, Mrs. Trahan, Mr. Johnson of Georgia, Ms. Ansari, Mr. Thanedar, Mr. Thompson of Mississippi, Mr. Krishnamoorthi, Ms. Salinas, Mrs. McIver, Mr. Carter of Louisiana, Ms. Wilson of Florida, Ms. Lee of Pennsylvania, Ms. Wasserman Schultz, Mr. Figures, Ms. Adams, Mr. Khanna, Mr. Meeks, Mr. Green of Texas, Ms. Tokuda, Ms. Rivas, and Mr. Mannion) introduced the following bill; which was referred to the Committee on Energy and CommerceA BILLTo direct the Secretary of Health and Human Services to study and report on the relationship between hair straighteners and uterine cancer, particularly among women of color.

1.

Short title

This Act may be cited as the Uterine Cancer Study Act of 2025.

2.

Study on relationship between hair straighteners and uterine cancer

(a)

Study

The Secretary of Health and Human Services, in coordination with the Commissioner of Food and Drugs and the Director of the National Institutes of Health, shall conduct a study on the relationship between hair straighteners and uterine cancer, with a focus on the increased incidence of such cancer among women of color. Such study shall— (1)review significant findings and recommendations from other studies regarding the relationship between hair straighteners and uterine cancer; (2)consider impacts on women and other individuals at risk of uterine cancer from all racial and ethnic backgrounds; (3)disaggregate the results of the study under this section according to whether the hair straighteners contain dyes or coloring, bleach, highlights, or perms; and (4)determine whether the Food and Drug Administration should impose additional testing requirements on the manufacturers of hair straightening products to ensure the safety of such products. (b)

Methodology

Not later than 45 days after the date of enactment of this Act, the Secretary shall submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate a description of the methodology that will be used to conduct the study under this section. (c)

Commencement

Not later than 180 days after the date of enactment of this Act, the Secretary shall commence the study under this section. (d)

Report

Not later than 2 years after the date of enactment of this Act, the Secretary shall complete the study under this section and submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate a report on the results of such study. (e)

Definition

In this section: (1)The term hair straightener means a chemical hair straightener. (2)The term Secretary means the Secretary of Health and Human Services.